Levonorgestrel, Pharmacokinetics, Efficacy and Safety 75[156] Collaborative Group on Hormonal Factors in Breast Cancer. Breast
cancer and hormonal contraceptives: further results. Contraception
1996;54:Suppl:1S-106S.
[157] Marchbanks PA, McDonald JA, Wilson HG, Folger SG, Mandel MG,
Daling JR, et al. Oral contraceptives and the risk of breast cancer. N
Engl J Med 2002; 6,2025–2032.
[158] Samson M, Porter N, Orekoya O, Hebert JR, Adams SA, Bennett CL,
Steck SE. Progestin and breast cancer risk: a systematic review. Breast
Cancer Res Treat. 2016;155:3-12.
[159] Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Pukkala E.
Cancer risk in women using the levonorgestrel-releasing intrauterine
system in Finland. Obstet Gynecol. 2014;124:292-299.
[160] Soini T, Hurskainen R, Grénman S, Mäenpää J, Paavonen J, Joensuu H,
Pukkala E. Levonorgestrel-releasing intrauterine system and the risk of
breast cancer: A nationwide cohort study. Acta Oncol. 2016;55:188-192.
[161] World Health Organization. Task Force on Post-Ovulatory Methods for
Fertility Regulation. Randomised controlled trial of levonorgestrel
versus the Yuzpe regimen of combined oral contraceptives for
emergency contraception. Lancet 1998;352:428–433.
[162] EllisonJ, Thomson AJ, Greer IA, Walker ID. Drug points: apparent
interaction between warfarin and levonorgestrel used for emergency
contraception. BMJ 2000; 321:1382.
[163] Cleland K, Raymond E, Trussell J, Cheng L, Zhu H. Ectopic pregnancy
and emergency contraceptive pills: a systematic review. Obstet Gynecol.
2010;115:1263-1266.
[164] Grimes DA, Raymond EG, Scott JB. Emergency contraception over the-
counter: the medical and legal imperatives. Obstet Gynecol 2001;
98:151–155.
[165] Raman-Wilms L,Tseng AL, Wighardt S, Einarson TR, Koren G. Fetal
genital effects of first-trimester sex hormone exposure: a metaanalysis.
Obstet Gynecol 1995; 85:141–149.
[166] Bracken MB. Oral contraception and congenital malformations in
offspring: a review and meta-analysis of the prospective studies. Obstet
Gynecol 1990;76: 552–557.
[167] Jatlaoui TC, Riley H, Curtis KM. Safety data for levonorgestrel,
ulipristal acetate and Yuzpe regimens for emergency contraception.
Contraception. 2016;93:93-112.